SecBot SecBot

Creating Hope Reauthorization Act of 2024

S. 4583 Sen. Bob Casey (D-PA) In committee
Bill text PDF
  1. Introduced Jun 18
  2. Committee Jun 18
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jun 18, 2024Next: Senate vote
862d ago Jun 18, 2024: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
8companies, 8 filings
Subscribe to see spend
Member trades
2trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

8 companies
Companies by sector
Biotech & Pharma 8
Search all 8 companies, their asks and price moves Subscribe

Summary

This bill extends the authority of the Secretary of Health and Human Services to issue priority review vouchers for treatments of rare pediatric diseases. Sec. 2, Extension of authority: The bill amends the Federal Food, Drug, and Cosmetic Act to change the expiration date for the authority to issue these vouchers from September 30, 2024, to September 30, 2030.

Summary of the bill text as introduced in Senate (Jun 18, 2024), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.